The British drugmaker AstraZeneca announced that its late-stage clinical trial evaluating Wainua for a rare heart condition failed to meet its primary …
Danish pharmaceutical giant Novo Nordisk has officially identified Australia as a high-priority global market for its highly anticipated weight loss pill Wegovy. …
China’s Sino Biopharmaceutical has secured two massive international agreements with AstraZeneca and GSK for respiratory medicine. With the Sino Biopharmaceutical respiratory drug …
In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney drug. Manufactured …
In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect endometriosis with …
Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever. This massive …
The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition is valued …
The daily Wegovy weight loss pill in UK pharmacies is now officially available through private channels following its recent regulatory clearance. The …
A recent Legionnaires’ disease outbreak in NYC has now escalated to 14 confirmed cases, up from just two cases reported early last …
The biotechnology leader Insilico Medicine announced a major strategic collaboration with global pharmaceutical giant Takeda. This Insilico Medicine Takeda partnership aims to …
The U.S. Food and Drug Administration (FDA) has officially upgraded the voluntary Utz potato chip recall to the highest risk level with …
The Australian Competition and Consumer Commission (ACCC) has taken decisive enforcement action against Lactalis Australia Pty Ltd, a major player in the …
The British drugmaker AstraZeneca announced that its late-stage clinical trial evaluating Wainua for a rare heart condition failed to meet
Danish pharmaceutical giant Novo Nordisk has officially identified Australia as a high-priority global market for its highly anticipated weight loss
China’s Sino Biopharmaceutical has secured two massive international agreements with AstraZeneca and GSK for respiratory medicine. With the Sino Biopharmaceutical
In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney
In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect
Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever.
The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition
The daily Wegovy weight loss pill in UK pharmacies is now officially available through private channels following its recent regulatory
A recent Legionnaires’ disease outbreak in NYC has now escalated to 14 confirmed cases, up from just two cases reported
The biotechnology leader Insilico Medicine announced a major strategic collaboration with global pharmaceutical giant Takeda. This Insilico Medicine Takeda partnership
The U.S. Food and Drug Administration (FDA) has officially upgraded the voluntary Utz potato chip recall to the highest risk
The Australian Competition and Consumer Commission (ACCC) has taken decisive enforcement action against Lactalis Australia Pty Ltd, a major player
